Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Power of Liquid Biopsy Tracking in Immunotherapy Treated Stage IV Melanoma

NCT06710093 is registered in ClinicalTrials.gov with Royal Marsden NHS Foundation Trust as lead sponsor.

NCT NCT06710093
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06710093 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Power of Liquid Biopsy Tracking in Immunotherapy Treated Stage IV Melanoma
Lead sponsor
Royal Marsden NHS Foundation Trust
Phase
Observational
Overall status
Not yet recruiting
Start date
February 1, 2025
Completion date
January 1, 2029
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic melanoma